ThomasStarck (Talk | contribs) |
ThomasStarck (Talk | contribs) |
||
Line 38: | Line 38: | ||
<p><i>This year iGEM Pasteur Paris attended multiple events with the purpose of spreading information about what iGEM is, inside and outside scientific fields. We decided not to limit ourselves to the Parisian region, so we travelled all around France and even to Denmark talking about our project NeuronArch. Our talks were not only with biologists but with physicists, mathematicians, chemists. We wanted also to speak with middle and high school students and even children, trying to vulgarize our project, synthetic biology and science in order to spark vocations. </i></p> | <p><i>This year iGEM Pasteur Paris attended multiple events with the purpose of spreading information about what iGEM is, inside and outside scientific fields. We decided not to limit ourselves to the Parisian region, so we travelled all around France and even to Denmark talking about our project NeuronArch. Our talks were not only with biologists but with physicists, mathematicians, chemists. We wanted also to speak with middle and high school students and even children, trying to vulgarize our project, synthetic biology and science in order to spark vocations. </i></p> | ||
</div> | </div> | ||
+ | <div class="separator mark"></div> | ||
<div class="block title"><h1>Engaging the Scientific Community</h1></div> | <div class="block title"><h1>Engaging the Scientific Community</h1></div> | ||
<div class="block half"> | <div class="block half"> |
Revision as of 16:54, 18 September 2018
This year iGEM Pasteur Paris attended multiple events with the purpose of spreading information about what iGEM is, inside and outside scientific fields. We decided not to limit ourselves to the Parisian region, so we travelled all around France and even to Denmark talking about our project NeuronArch. Our talks were not only with biologists but with physicists, mathematicians, chemists. We wanted also to speak with middle and high school students and even children, trying to vulgarize our project, synthetic biology and science in order to spark vocations.
Engaging the Scientific Community
Translational Research Day
The Translational Research Day is a full day mini symposium dedicated to translational research. The event was organized at Institut Pasteur (Paris) from 2007 by the former Center for Human Immunology. Since 2015, it is organized by the Translational Research Center. This year, it focuses on gathering scientists working on neuropsychology, microbiota and angering. We had the pleasure to share our ideas and present to the scientific world for the first time our team’s projet NeuronArch through our first poster.
Young Researchers in Life Sciences
The Young Researchers in Life Sciences (YRLS) is one of the most important spring conference. We participated in the 9th edition conference held from the May 2nd -4th at Ecole Normale Supérieure, Paris. Young researchers presented their projects through a scientific poster, like we did, and gave us some precious advices on the experiments to come.
VIVATECH
Viva Technology is a commercial fair dedicated to technological innovations in Paris. On may 24th, we attended the “welcome to the bionic age” conference hosted by David Aguilar Amphoux, Moran Cerf, and Ernesto Martinez Villalpando. During one hour, they spoke about bionic prosthesis and how do we make, use and connect them directly to the human brain.
Biofilms 8
Members of our team flew to Denmark to attend Biofilms 8 conference held in May 27-29 in Aarhus University. The conference gathered experts from all around the world in the field of bacterial communities and biofilm way of life. We presented our poster during poster sessions to biologists, doctors and engineers. This conference allowed us to further exchange with Françoise Van Bambeke, Doctor in Pharmaceutical Science in the University of Louvain, Belgium, who has been working for years on the pharmacological fight against biofilm. Exchanging with her confirmed us that acting on Quorum sensing to avoid biofilm formation could be an efficient approach, and she advised us to try to investigate on the advantages of our synthetic biology approach compared to classic pharmacologic solutions.